IMO SANOFI PASTEUR | Sanofi | hazardous waste violation | 2014 | EPA | $77,643 |
NOVOZYMES BIOLOGICALS, INC. | Novo Holdings A/S | environmental violation | 2016 | EPA | $8,400 |
VERSUM MATERIALS, INC. | Merck KGaA (EMD) | hazardous waste violation | 2020 | EPA | $17,600 |
MERCK SHARP & DOHME CORP. | Merck | hazardous waste violation | 2023 | EPA | $6,250 |
EM INDUSTRIES, INC. | Merck KGaA (EMD) | environmental violation | 2000 | EPA | $5,000 |
NOVO NORDISK BIOCHEM, N.A., INC. | Novo Holdings A/S | environmental violation | 2000 | EPA | $5,000 |
UCB CHEMICAL CORPORATION | UCB | environmental violation | 2001 | EPA | $6,824 |
MEDIMMUNE DISTRIBUTION LLC | AstraZeneca | environmental violation | 2005 | EPA | $21,125 |
KING PHARMACEUTICALS | Pfizer | air pollution violation | 2013 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,200,000 |
SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC. ( SB) | Merck | environmental violation | 2007 | EPA | $40,950 |
ASTRAZENECA PLP | AstraZeneca | environmental violation | 2021 | EPA | $18,960 |
LAFAYETTE PHARMACEUTICALS, INC. | Mallinckrodt | environmental violation | 2001 | EPA | $17,600 |
ALPHARMA, INC. | Zoetis | environmental violation | 2000 | EPA | $5,000 |
PHIBRO-TECH, INC. | Phibro Animal Health | environmental violation | 2000 | EPA | $5,000 |
research organics | Merck KGaA (EMD) | hazardous waste violation | 2003 | EPA | $159,672 |
PHARMACIA & UPJOHN COMPANY, LLC. | Pfizer | environmental violation | 2004 | EPA | $5,000 |
ABBOTT LABS-N CHICAGO PLANT | AbbVie | air pollution violation | 2004 | EPA | $162,595 |
Pharmacia & Upjohn Company | Pfizer | air pollution violation | 2005 | EPA | $676,250 |
Novartis Animal Health US, Inc. | Eli Lilly | environmental violation | 2006 | EPA | $6,500 |
ABBOTT LABS - N. CHICAGO PLANT | AbbVie | air pollution violation | 2006 | EPA | $475,672 |
Alpharma Inc. (Chicago Heights) | Zoetis | environmental violation | 2006 | EPA | $29,737 |
ELI LILLY AND COMPANY | Eli Lilly | air pollution violation | 2011 | EPA | $337,500 |
Phibro-Tech, Inc. | Phibro Animal Health | hazardous waste violation | 2008 | EPA | $151,603 |
ELI LILLY & COMPANY - TIPPECANOE LABS | Eli Lilly | air pollution violation | 2009 | EPA | $12,000 |
ABBOTT LABS - N. CHICAGO PLANT | AbbVie | air pollution violation | 2011 | EPA | $135,756 |
CSL Behring LLC | CSL Limited | air pollution violation | 2015 | EPA | $62,780 |
ACTAVIS,INC. | AbbVie | hazardous waste violation | 2015 | EPA | $30,800 |
Pharmacia and Upjohn Company LLC | Pfizer | environmental violation | 2017 | EPA | $34,170 |
Aldrich Chemical | Merck KGaA (EMD) | hazardous waste violation | 2018 | EPA | $5,000 |
Aldrich Chemical, LLC | Merck KGaA (EMD) | hazardous waste violation | 2018 | EPA | $5,000 |
KREMERS URBAN PHARMACEUTICALS INC | Lannett Co. | air pollution violation | 2018 | EPA | $285,000 |
CSL BEHRING LLC | CSL Limited | air pollution violation | 2021 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $527,144 |
MALLINCKRODT, INC | Mallinckrodt | air pollution violation | 2004 | EPA | $80,160 |
CAMBREX CHARLES CITY, INC | Cambrex | hazardous waste violation | 2006 | EPA | $106,749 |
SIGMA ALDRICH MFG LLC | Merck KGaA (EMD) | air pollution violation | 2007 | EPA | $55,000 |
ABBOTT LABORATORIES | Abbott Laboratories | hazardous waste violation | 2008 | EPA | $25,033 |
TEVA PHARMACEUTICALS USA INC | Teva Pharmaceutical Industries | air pollution violation | 2013 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,250,000 |
BOEHRINGER INGELHEIM VETMEDICA, INC | Eli Lilly | air pollution violation | 2011 | EPA | $900,000 |
BOEHRINGER INGELHEIM VETMEDICA, INC | Eli Lilly | hazardous waste violation | 2012 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $338,475 |
MALLINCKRODT, LLC | Mallinckrodt | hazardous waste violation | 2013 | EPA | $449,740 |
GLAXOSMITHKLINE VACCINES | GlaxoSmithKline | air pollution violation | 2014 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $172,900 |
DePuy Synthes | Johnson & Johnson | hazardous waste violation | 2019 | EPA | $51,750 |
Amgen Inc. | Amgen | hazardous waste violation | 2007 | EPA | $24,368 |
Advanced Sterilization Products, Div of Ethicon | Johnson & Johnson | environmental violation | 2014 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $136,800 |
Genentech | Roche | environmental violation | 2023 | EPA | $158,209 |
Janssen Pharmaceutica Inc. | Johnson & Johnson | environmental violation | 2004 | EPA | $7,700 |
NOVARTIS PRODUCTS | Novartis | environmental violation | 2000 | EPA | $13,200 |
NOVARTIS CONSUMER HEALTH, INC. | Novartis | environmental violation | 2000 | EPA | $5,000 |
BRISTOL-MYERS SQUIBB COMPANY | Bristol-Myers Squibb | environmental violation | 2000 | EPA | $5,000 |
Johnson & Johnson | Johnson & Johnson | environmental violation | 2004 | EPA | $5,000 |
Imclone Systems, Inc. | Eli Lilly | employment discrimination | 2005 | EEOC | $85,000 |
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. | Bausch Health | benefit plan administrator violation | 2016 | EBSA | $10,001 |
BIOVAIL AMERICAS CORP. | Bausch Health | benefit plan administrator violation | 2012 | EBSA | $10,001 |
CHEROKEE PHARMACEUTICALS LLC | Merck | benefit plan administrator violation | 2011 | EBSA | $10,001 |
NOVARTIS PHARMACEUTICALS CORPORATION | Novartis | benefit plan administrator violation | 2006 | EBSA | $10,001 |
IMMUNOMEDICS, INC. EMPLOYEES' 401(K) SAVINGS PLAN | Gilead Sciences | benefit plan administrator violation | 2001 | EBSA | $10,001 |
Seagen Pharmaceuticals, Inc. | Pfizer | benefit plan administrator violation | 2001 | EBSA | $29,974 |
PERNIX THERAPEUTICS, LLC | Currax Pharmaceuticals | benefit plan administrator violation | 2019 | EBSA | $10,001 |
Pfizer H.C.P. Corporation | Pfizer | Foreign Corrupt Practices Act | 2012 | DOJ_CRIMINAL | $15,000,000 |
Johnson & Johnson | Johnson & Johnson | Foreign Corrupt Practices Act | 2011 | DOJ_CRIMINAL | $21,400,000 |
Novo Nordisk A/S | Novo Holdings A/S | kickbacks and bribery | 2009 | DOJ_CRIMINAL | $9,000,000 |
Micrus Corporation | Johnson & Johnson | Foreign Corrupt Practices Act | 2005 | DOJ_CRIMINAL | $450,000 |
Teva Pharmaceutical Industries Ltd | Teva Pharmaceutical Industries | Foreign Corrupt Practices Act | 2016 | DOJ_CRIMINAL | $283,177,348 |
Novartis Hellas S.A.C.I. et al. | Novartis | Foreign Corrupt Practices Act | 2020 | DOJ_CRIMINAL | $233,000,000 |
AstraZeneca LP | AstraZeneca | False Claims Act and related | 2015 | DOJ_CIVIL | $7,900,000 |
Daiichi Sankyo Inc. | Daiichi Sankyo | False Claims Act and related | 2015 | DOJ_CIVIL | $39,000,000 |
Abbott Laboratories | Abbott Laboratories | False Claims Act and related | 2013 | DOJ_CIVIL | $5,475,000 |
Sanofi-Aventis U.S. Inc. | Sanofi | False Claims Act and related | 2012 | DOJ_CIVIL | $109,000,000 |
St. Jude Medical Inc. | Abbott Laboratories | kickbacks and bribery | 2011 | DOJ_CIVIL | $16,000,000 |
Acclarent Inc. | Johnson & Johnson | False Claims Act and related | 2016 | DOJ_CIVIL | $18,000,000 |
Genentech Inc. | Roche | False Claims Act and related | 2016 | DOJ_CIVIL | $33,500,000 |
OSI Pharmaceuticals LLC | Astellas Pharma | False Claims Act and related | 2016 | DOJ_CIVIL | $67,000,000 |
Pfizer Inc. | Pfizer | False Claims Act and related | 2016 | DOJ_CIVIL | $784,600,000 |
AstraZeneca LP | AstraZeneca | False Claims Act and related | 2015 | DOJ_CIVIL | $46,500,000 |
Cephalon Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2015 | DOJ_CIVIL | $7,500,000 |
Astellas Pharma US Inc. | Astellas Pharma | False Claims Act and related | 2014 | DOJ_CIVIL | $7,300,000 |
Teva Pharmaceuticals USA Inc. and IVAX LLC | Teva Pharmaceutical Industries | False Claims Act and related | 2014 | DOJ_CIVIL | $27,600,000 |
Genzyme Corp. | Sanofi | False Claims Act and related | 2013 | DOJ_CIVIL | $22,280,000 |
ISTA Pharmaceuticals, Inc. | Bausch Health | False Claims Act and related | 2013 | DOJ_CIVIL | $33,500,000 |
Amgen Inc. | Amgen | False Claims Act and related | 2013 | DOJ_CIVIL | $24,900,000 |
St. Jude Medical Inc. | Abbott Laboratories | False Claims Act and related | 2012 | DOJ_CIVIL | $3,650,000 |
Dava Pharmaceuticals Inc. | Endo International | False Claims Act and related | 2012 | DOJ_CIVIL | $11,000,000 |
Serono Laboratories Inc. | Merck KGaA (EMD) | False Claims Act and related | 2011 | DOJ_CIVIL | $44,300,000 |
Dey Inc. | Viatris | False Claims Act and related | 2010 | DOJ_CIVIL | $280,000,000 |
Roxane Laboratories Inc. | Hikma Pharmaceuticals | False Claims Act and related | 2010 | DOJ_CIVIL | $280,000,000 |
Abbott Laboratories Inc. | AbbVie | False Claims Act and related | 2010 | DOJ_CIVIL | $126,500,000 |
St. Jude Medical Inc. | Abbott Laboratories | False Claims Act and related | 2010 | DOJ_CIVIL | $3,725,000 |
Schwarz Pharma Inc. | UCB | False Claims Act and related | 2010 | DOJ_CIVIL | $22,000,000 |
Alpharma Inc. | Pfizer | False Claims Act and related | 2010 | DOJ_CIVIL | $42,500,000 |
Eon Labs Inc. | Novartis | False Claims Act and related | 2010 | DOJ_CIVIL | $3,500,000 |
IVAX Pharmaceuticals | Teva Pharmaceutical Industries | False Claims Act and related | 2009 | DOJ_CIVIL | $14,000,000 |
AstraZeneca Pharmaceuticals | AstraZeneca | False Claims Act and related | 2009 | DOJ_CIVIL | $2,600,000 |
Mylan Pharmaceuticals and UDL Laboratories | Viatris | False Claims Act and related | 2009 | DOJ_CIVIL | $118,000,000 |
Ortho McNeil Pharmaceutical | Johnson & Johnson | False Claims Act and related | 2009 | DOJ_CIVIL | $3,400,000 |
Aventis Pharmaceutical Inc. | Sanofi | False Claims Act and related | 2009 | DOJ_CIVIL | $95,500,000 |
Merck & Company | Merck | False Claims Act and related | 2008 | DOJ_CIVIL | $650,000,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | off-label or unapproved promotion of medical products | 2007 | DOJ_CIVIL | $515,000,000 |
Aventis Pharmaceuticals Inc. | Sanofi | False Claims Act and related | 2007 | DOJ_CIVIL | $190,000,000 |
Medicis Pharmaceutical Corporation | Bausch Health | off-label or unapproved promotion of medical products | 2007 | DOJ_CIVIL | $9,800,000 |
King Pharmaceuticals | Pfizer | False Claims Act and related | 2005 | DOJ_CIVIL | $124,000,000 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2005 | DOJ_CIVIL | $150,000,000 |